Real-world outcomes of long-term use of silexan in patients with anxiety disorders: a single-centre experience | Synapse

⌘+K

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trialsmeta-analysis · 2024 · 5 citations
2162. EFFICACY OF SILEXAN IN PATIENTS WITH A MAJOR DEPRESSIVE EPISODE – RESULTS FROM A MULTI-CENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO- AND REFERENCE-CONTROLLED PHASE III TRIAL2025
3Efficacy of Silexan in Patients with a Major Depressive Episode – First Results from a Multi-centre, Double-blind, Randomised, Placebo- and Reference-controlled Phase III Trial2024 · 1 citations
4The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) trial: protocol for a 12-week randomised controlled trial of adjunctive Silexan for PTSDRandomized Controlled Trial · 2026
5Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial2024 · 10 citations

More from International Journal of Psychiatry in Clinical Practice